Trade Summary

4 months ago, Alvarez Ralph, serving as Dir at Eli Lilly & Co (LLY), purchased 758 shares at $660.25 per share, for a total transaction value of $500,473.00. Following this transaction, Alvarez Ralph now holds 55,753 shares of LLY.

This purchase represents a 1.00% increase in Alvarez Ralph's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 13, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, August 14, 2025, 1 day after the trade was made.

Eli Lilly & Co operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.